More than half of internal medicine residents at Massachusetts General Hospital in Boston say they were not adequately trained in addiction and other substance use disorders, according to a new survey.
A new campaign launched by the Centers for Disease Control and Prevention encourages smokers to talk with their physician about quitting. The “Talk With Your Doctor” campaign also provides materials for physicians to help their patients give up cigarettes.
Scientists at Johns Hopkins University have identified a compound that stopped mice addicted to cocaine from wanting the drug. The compound has been proven safe for humans and is undergoing further animal testing, in preparation for possible clinical trials for people addicted to cocaine.
Felons, including sex offenders, are allowed to work as substance abuse counselors in California because of lax rules, according to a new report.
Primary care physicians should ask their adult patients about their drinking habits, and counsel those whose alcohol use is risky, according to a new report.
An experimental anti-cocaine vaccine blocks the drug from reaching the brain, according to a study of non-human primates. Scientists at Weill Cornell Medical Center in New York say human trials of the vaccine may begin within a year.
Older teens and young adults with mental health issues who participate in community-based treatment programs report lower levels of substance use disorders, a new government report finds.
Nine “recovery courts” will be created in Tennessee to combat substance abuse and mental health issues, state officials announced this week. They will combine services currently found in drug courts, mental health courts and veterans courts.
The Neurological Center for Pain’s Chronic Pain Rehabilitation Program at the Cleveland Clinic has created a Chemical Education Track designed specifically for patients with chronic non-cancer pain who also have a therapeutic opioid addiction. Initial results are promising.
Scientists have blocked heroin addiction relapse in rats using a vaccine, according to U.S. News & World Report. They hope the vaccine will be ready for human testing later this year.